Obesity alters how medications work, increasing the risk of underdosing, overdosing, and unknown interactions. Are package ...

U.S. regulators are trying to shut down the industry for compounded weight-loss drugs, which could result in higher costs or ...

Instead of simply suggesting she lose weight and return when she had done so — advice many people with obesity are accustomed to hearing — Elperin tracked her patient’s weight history for ...

What is our current understanding of how differences in sex can affect obesity prevalence, comorbidities, and treatment ...

Among the 2,225 adults in the study, all under 60 years of age, 39.7% had obesity as defined only by higher BMI, while 39.1% had confirmed excess adiposity when using diagnostic criteria recently laid ...

New research being presented at this year's European Congress on Obesity (ECO 2025, Malaga, Spain, 11–14 May) shows that ...

Neuroscientists at Virginia Tech’s Fralin Biomedical Research Institute at VTC will investigate how obesity influences brain ...

PORTLAND, Ore. (KATU) — "I want to be that fun, energetic, outgoing grandma that can still enjoy doing things," said 51-year-old Cristi Berens. For some time, she didn't think that version of ...

“While this trial alone is very good, this just bodes extremely well for their trial in obesity patients,” Gade said. The late-stage trial found that 13 per cent to 18 per cent of patients ...

Scotland has become the first country in the UK to back NHS use of Eli Lilly’s obesity therapy Mounjaro, clearing it to assist weight management in eligible patients. The Scottish Medicines ...

"While this trial alone is very good, this just bodes extremely well for their trial in obesity patients," said Gade. The late-stage trial found that 13% to 18% of patients given the drug ...

(Reuters) -Eli Lilly's experimental pill worked as well as blockbuster drug Ozempic to lower weight and blood sugar in a trial of diabetes patients ... that sales of obesity treatments could ...